TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s August 6, 1993
